Results 11 to 20 of about 32,738 (290)

The use of ROTEM in Detection of Coagulopathy and Altered Hemostasis in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. [PDF]

J Surg Oncol
ABSTRACT Background Patients undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) are at risk of coagulopathy. This study aims to evaluate the potential role of rotational thromboelastometry (ROTEM) in detecting alterations in coagulation during and after CRS/HIPEC.
Mashat A, Taqi K, Parapini M, Chen J, Trudeau J, Wilson J, Hamilton TD, MacNeill AJ.   +7 more
europepmc   +2 more sources

Hyperthermic intraperitoneal chemotherapy: Ideal and reality

Asian Journal of Surgery
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) is a new adjuvant therapy for the treatment of abdominal malignant tumors and metastases, which has shown great potential.
Fan-He Dong, Yu-Qiang Shan, Wen-Cheng Kong, Hao-Ran Wei, Lin-Po Zhou, Ye-Bin Yang, Jing Shi, Cheng-Hao Ji, Yi-Jia Zhang   +8 more
doaj   +3 more sources

Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy

Annals of Hepatology, 2012
Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a consequence of this treatment modality.
Heriberto Medina-Franco, Daniel Zamora-Valdés, Ariadne Sánchez-Ramón, Gabriela Trejo-Gómez   +3 more
doaj   +3 more sources

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2021
Objective To investigate the therapeutic efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) as consolidation treatment after completing first-line treatment in patients with advanced ovarian cancer.
Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Joon Mo Lee   +8 more
doaj   +1 more source

Current Situation of Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinoma

Zhongliu Fangzhi Yanjiu, 2021
Peritoneal carcinoma is a kind of malignant tumor which occurs and develops on the peritoneum, including primary and secondary tumors. Hyperthermic intraperitoneal chemotherapy is a combined therapy of intraperitoneal perfusion, hyperthermia and ...
ZHAN Hongjie, LIANG Han
doaj   +1 more source

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Journal of Clinical Oncology, 2023
PURPOSE In patients with peritoneal metastasis (PM) from gastric cancer (GC), chemotherapy is the treatment of choice. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are still being debated. This randomized, controlled,
B. Rau, Hauke Lang, Alfred Koenigsrainer, Ines Gockel, H. Rau, Hendrik Seeliger, Christian Lerchenmueller, D. Reim, Roger Wahba, Martin Angele, S. Heeg, Tobias Keck, Arved Weimann, Stefan Topp, P. Piso, A. Brandl, Silke Schuele, Peter Jo, J. Pratschke, Sandra Wegel, A. Rehders, N. Moosmann, J. Gaedcke, Volker Heinemann, E. Trips, Markus Loeffler, P. Schlag, P. Thuss-Patience   +27 more
semanticscholar   +1 more source

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial.

JAMA Surgery, 2023
Importance Peritoneal metastasis in patients with locally advanced colon cancer (T4 stage) is estimated to recur at a rate of approximately 25% at 3 years from surgical resection and is associated with poor prognosis.
Á. Arjona-Sánchez, E. Espinosa-Redondo, A. Gutiérrez-Calvo, J. Segura-Sampedro, E. Pérez-Viejo, Vanessa Concepción-Martín, S. Sánchez-García, A. García-Fadrique, I. Prieto-Nieto, P. Barrios-Sánchez, J. Torres‐Melero, M. Ramirez Faraco, A. Prada-Villaverde, J. Carrasco-Campos, M. Artiles-Armas, P. Villarejo-Campos, G. Ortega-Pérez, Emrique Boldo-Roda, J. Sánchez-Hidalgo, Á. Casado-Adam, L. Rodriguez-Ortiz, E. Aranda, M. Cano-Osuna, César Díaz-López, A. Romero-Ruiz, J. Briceño-Delgado, S. Rufián-Peña   +26 more
semanticscholar   +1 more source

Cytoreductive surgery ± hyperthermic intraperitoneal chemotherapy and the value of markers for acute kidney injury. [PDF]

Asian Biomed (Res Rev News)
Editorial Office of Asian Biomedicine.
europepmc   +3 more sources

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

JAMA Surgery, 2022
Key Points Question Does hyperthermic intraperitoneal chemotherapy (HIPEC) after primary or interval cytoreductive surgery increase survival in patients with ovarian cancer?
M. Lim, Suk-Joon Chang, Boram Park, H. Yoo, C. Yoo, B. Nam, Sang-Yoon Park   +6 more
semanticscholar   +1 more source

Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases

Molecular Cancer, 2023
Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential treatment that can prolong survival of patients with peritoneal metastases after cytoreductive surgery.
Qiang-Wei Wang, Peng Liu, Yingfei Wen, Kuan Li, Bo Bi, Binbin Li, Miaojuan Qiu, Shiqiang Zhang, You Li, Jia Li, Hengxing Chen, Yuan Yin, Leli Zeng, Changhua Zhang, Yulong He, Jing Zhao   +15 more
semanticscholar   +1 more source